Veterinary APIs Market Update: Price Trends & Key Insights – February 2025

Veterinary APIs Price Index (VPi):

February 12th  66.33

February 19th   66.26

February 26th    66.28

The veterinary APIs market has shown a moderate recovery after the Chinese New Year holiday (January 28-February 05). Downstream restocking demand has been observed along with the restoration of in-land logistics capacity.

Certain products, including Tylosin, Oxytetracycline, Neomycin Sulfate, and Tilmicosin, have witnessed notable price hikes owing to limited supply and strong pricing strategies implemented by manufacturers. Conversely, products like Florfenicol and Doxycycline are encountering price fluctuations due to fierce competition among manufacturers.

The market is anticipated to uphold a consolidation trend in the short run.

On February 26th, Florfenicol's average market price stood at 194 yuan/kg, showing a 0.69% decline from the previous week. The current supply is abundant, leading to intense competition among manufacturers, which has restrained the product's price. Despite this, due to cost and profit margin pressures, the potential for further price reductions is constrained. In the near future, the market is anticipated to exhibit weak performance with slight price variations.

Driven by continuous large-scale purchases from major breeding companies, the price of Tiamulin has rapidly escalated. As of February 26, its average market price stood at 240 yuan/kg, marking a 4.8% increase from the previous week and a 10.6% rise since 2025, showcasing a significant upward trend.

On the 26th, the average price of Doxycycline stood at 368 yuan/kg, marking a 0.92% decrease from the previous week. Since February, there has been a 5.17% decline from the peak price. The increase in production capacity has resulted in abundant supply, while the existing pre-holiday inventory levels have not been completely exhausted, leading to subdued demand. In the near future, market prices might experience minor fluctuations, with a low probability of a sharp decline to minimum levels.

On February 26th, Tylosin Tartrate's average market price stood at 236 yuan/kg, marking a 3.18% increase from the early February. Meanwhile, on the 26th, Tilmicosin recorded an average market price of 316 yuan/kg, reflecting a 4.3% surge .

The notable escalation in market prices can be largely attributed to the deliberate pricing tactics and supply management strategies employed by upstream manufacturers. By upholding elevated price points and regulating the availability of these products, manufacturers have effectively stimulated a rise in market values. Despite a steady demand, the constrained supply dynamics have directly propelled the market prices upwards.

The vitamin market has displayed a divergent trend, operating within a narrow range. Transactions for VC and Inositol have been sluggish, with trade prices trending weakly. Downstream, the demand for VB12 remains weak, while market prices have stayed largely stable. Nicotinamide prices have stabilized following an incident at an Indian factory impacting nicotinic acid production, leading some manufacturers to suspend quotations. Upstream VB1 and VB6 factories are keen on maintaining high prices, whereas VD3 and folic acid market prices stand firm. Other categories see weakly stable prices, with average inquiries and transactions. The market is anticipated to persist in a weakly stable state in the short term.

Mainstream manufacturers are upholding price stability, while trade channels show an increasing willingness to participate in sales, leading to a market price index that remains stable with slight fluctuations. A significant development occurred on February 24th, as Zhejiang Medicine (ZMC) decided to cease price quoting for feed-grade Vitamin A.

Vitamin E exports are holding steady, with domestic terminals buying as needed, resulting in a somewhat subdued market performance within a limited range.

Notably, beginning February 24th, Zhejiang Medicine has halted price quotations for feed-grade Vitamin E.

The mainstream factories' performance has shown consistency after the holiday, with market terminals restocking based on rigid demand. Negotiated transactions are limited, and the market price index is displaying a downward trend.

Some Vitamin K3 manufacturers have suspended quotations and contracts, with terminals restocking according to fixed demand. Major businesses have halted production for maintenance, resulting in a stabilization of the market price index.

The amino acid market is currently witnessing varied trading activities, with notable shifts in price trends for different types of amino acids. Here's a snapshot of the market dynamics:

Lysine: Manufacturers have reduced quotations for 98% lysine, leading to subdued inquiries and transactions. In contrast, 70% lysine prices remain stable, with increased trading interest.

Threonine: Recent declines in threonine quotations have created a cautious market sentiment, prompting a 'wait-and-see' approach among traders.

Methionine: Manufacturers have maintained stable prices, driven by consistent demand for confirmed orders. Some suppliers have even raised prices for liquid methionine.

Valine: Quotations for valine are on the weaker side as downstream users struggle to stimulate demand.

Tryptophan: Manufacturers have slightly lowered tryptophan prices in the current market scenario.

In other developments:

Eppen's L-Isoleucine has successfully cleared the EU's quality and safety assessment, allowing entry into the EU market.  Xiangyu JINGU Biochemical has secured safety and quality certification for L-Threonine in the EU.

These updates highlight the evolving landscape of the amino acid market and the regulatory achievements of key players in ensuring product quality and market access.